Abstract | OBJECTIVE: DESIGN: Multicenter, prospective, randomized, controlled trial. SETTING: Seven intensive care units. PATIENTS: INTERVENTIONS: MEASUREMENTS AND MAIN RESULTS: Duration and complications of NIV and mechanical ventilation, endotracheal intubation, discharge from intensive care unit and hospital, mortality at day 28, adverse and serious adverse events were recorded. Follow-up lasted until 28 days since enrollment. Intubation rate did not significantly differ between groups (24.5% vs. 30.4% with or without helium, p = .35). No difference was observed in terms of improvement of arterial blood gases, dyspnea, and respiratory rate between groups. Duration of noninvasive ventilation, length of stay, 28-day mortality, complications and adverse events were similar, although serious adverse events tended to be lower with helium (10.8% vs. 19.6%, p = .08). CONCLUSIONS:
|
Authors | Salvatore Maurizio Maggiore, Jean-Christophe M Richard, Fekri Abroug, Jean Luc Diehl, Massimo Antonelli, Philippe Sauder, Jordi Mancebo, Miquel Ferrer, Francois Lellouche, Laurent Lecourt, Gaetan Beduneau, Laurent Brochard |
Journal | Critical care medicine
(Crit Care Med)
Vol. 38
Issue 1
Pg. 145-51
(Jan 2010)
ISSN: 1530-0293 [Electronic] United States |
PMID | 19730250
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- Aged
- Blood Gas Analysis
- Critical Care
(methods)
- Female
- Helium
(therapeutic use)
- Humans
- Intensive Care Units
- Length of Stay
- Male
- Masks
- Middle Aged
- Oxygen
(therapeutic use)
- Oxygen Inhalation Therapy
(methods)
- Probability
- Prognosis
- Prospective Studies
- Pulmonary Disease, Chronic Obstructive
(diagnosis, therapy)
- Pulmonary Gas Exchange
- Recurrence
- Respiration, Artificial
(methods)
- Respiratory Function Tests
- Risk Assessment
- Severity of Illness Index
- Treatment Outcome
|